Jeffrey A. Zonder

1 article listing Jeffrey A. Zonder in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study Nature Communications